Production and characterization of vaccines based on flaviviruses defective in replication

被引:74
作者
Mason, Peter W.
Shustov, Alexandr V.
Frolov, Ilya
机构
[1] Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Pathol, Galveston, TX 77555 USA
[3] Univ Texas, Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA
关键词
pseudoinfectious viruses; flavivirus vaccines; subviral particles;
D O I
10.1016/j.virol.2006.04.003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To develop new vaccine candidates for flavivirus infections, we have engineered two flaviviruses, yellow fever virus (YFV) and West Nile virus (WNV), that are deficient in replication. These defective pseudoinfectious viruses (PIVs) lack a functional copy of the capsid (C) gene in their genomes and are incapable of causing spreading infection upon infection of cells both in vivo and in vitro. However, they produce extracellular E protein in form of secreted subviral particles (SVPs) that are known to be an effective immunogen. PIVs can be efficiently propagated in trans-complementing cell lines making high levels of C or all three viral structural proteins. PIVs derived from YFV and WNV, demonstrated very high safety and immunization produced high levels of neutralizing antibodies and protective immune response. Such defective flaviviruses can be produced in large scale under low biocontainment conditions and should be useful for diagnostic or vaccine applications. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:432 / 443
页数:12
相关论文
共 46 条
[1]   Humoral and cellular immune response to RNA immunization with flavivirus Replicons derived from tick-borne encephalitis virus [J].
Aberle, JH ;
Aberle, SW ;
Kofler, RA ;
Mandl, CW .
JOURNAL OF VIROLOGY, 2005, 79 (24) :15107-15113
[2]  
Aberle JH, 1999, J IMMUNOL, V163, P6756
[3]   A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication [J].
Bredenbeek, PJ ;
Kooi, EA ;
Lindenbach, B ;
Huijkman, N ;
Rice, CM ;
Spaan, WJM .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :1261-1268
[4]   Yellow fever Japanese encephalitis chimeric viruses: Construction and biological properties [J].
Chambers, TJ ;
Nestorowicz, A ;
Mason, PW ;
Rice, CM .
JOURNAL OF VIROLOGY, 1999, 73 (04) :3095-3101
[5]   DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus [J].
Colombage, G ;
Hall, R ;
Pavy, M ;
Lobigs, M .
VIROLOGY, 1998, 250 (01) :151-163
[6]   West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays [J].
Davis, BS ;
Chang, GJJ ;
Cropp, B ;
Roehrig, JT ;
Martin, DA ;
Mitchell, CJ ;
Bowen, R ;
Bunning, ML .
JOURNAL OF VIROLOGY, 2001, 75 (09) :4040-4047
[7]  
FAYZULIN R, IN PRESS VIROLOGY
[8]   RECOMBINANT VACCINIA VIRUSES CO-EXPRESSING DENGUE-1 GLYCOPROTEINS PRM AND E-INDUCE NEUTRALIZING ANTIBODIES IN MICE [J].
FONSECA, BAL ;
PINCUS, S ;
SHOPE, RE ;
PAOLETTI, E ;
MASON, PW .
VACCINE, 1994, 12 (03) :279-285
[9]  
GENTNER D, 1982, LANGUAGE DEV, V2, P31
[10]  
Gerasimon G, 2005, SOUTH MED J, V98, P653, DOI 10.1097/01.SMJ.0000157537.11806.DC